Discovery Life Sciences Email Format
Biotechnology ResearchAlabama, United States501-1000 Employees
Discovery Life Sciences is a biotechnology research company based in Huntsville, Alabama. It positions itself as a biospecimen and biomarker specialist, delivering highly characterized human biospecimens and cellular starting materials alongside multi-omic analytical services to support cell and gene therapy and precision medicine programs for cancer, infectious disease, and other complex conditions. The firm emphasizes an integrated platform designed for speed and large-scale capacity, routinely managing hundreds of studies and testing thousands of biospecimens as a single vendor to reduce the need for transfers between multiple suppliers, and it maintains a large recallable donor pool offering both Research Use Only and GMP-grade materials for scalable programs. In May 2026, Discovery Life Sciences launched Luminos Comprehensive, a 164-gene pan-tumor genomic profiling panel validated on FFPE tissue as an IVDR-compliant laboratory-developed test, deployed in-house at its Kassel facility under Health Institution status. The company has pursued partnerships to integrate AI-enabled image analysis into pathology services and expand its clinical-trial support, including collaborations with MindPeak and PathAI.